Turn Therapeutics (TTRX) Equity Average (2024 - 2026)

Turn Therapeutics' quarterly Equity Average came in at $5.4 million in Q1 2026, up 1584.8% year-on-year from $320639.0 in Q1 2025, and up 108.15% quarter-over-quarter from $2.6 million in Q4 2025.

Turn Therapeutics has reported Equity Average for 3 years, with the latest figure at $5.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Equity Average rose 1584.8% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 1584.8% YoY), and the FY2025 full-year result was $2.3 million, changed N/A from the prior year.
  • Equity Average for Q1 2026 stood at $5.4 million, up from $2.6 million in the prior quarter.
  • The five-year high for Equity Average was $5.4 million in Q1 2026, with the low at -$295865.5 in Q4 2024.
  • Average Equity Average over 3 years is $1.7 million, with a median of $661364.5 recorded in 2025.
  • Year-over-year, Equity Average surged 977.21% in 2025 and surged 1584.8% in 2026.
  • Tracing TTRX's Equity Average over 3 years: stood at -$295865.5 in 2024, then surged by 977.21% to $2.6 million in 2025, then jumped by 108.15% to $5.4 million in 2026.
  • The last three Equity Average figures came in at $5.4 million (Q1 2026), $2.6 million (Q4 2025), and $661364.5 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.76 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 21.35 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.01 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.34 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 932.28 Mn
10 Turn Therapeutics 188.06 Mn 188.06 Mn - 5.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.40 Mn
Dec 31, 2025 2.60 Mn
Sep 30, 2025 661,364.50
Mar 31, 2025 320,639.00
Dec 31, 2024 -295,865.50